- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 98.7M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.42B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.33B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.21B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.24B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.64B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.55B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.89B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.83B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $78.2M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $140.11M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 102.36M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $6.32M |
| Dividends Paid restated | Q1 2025 · Mar 31, 2024 | $351K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $24.73M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $10.26M |
| Net Income | Q1 2025 · Mar 31, 2024 | $8.53M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $27.63M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $183.03M |
| Revenue | Q1 2025 · Mar 31, 2024 | $267.49M |